The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice

被引:0
|
作者
Frank Michael Klenke
Martha-Maria Gebhard
Volker Ewerbeck
Amir Abdollahi
Peter E Huber
Axel Sckell
机构
[1] University of Bern,Department of Orthopedic Surgery, Inselspital
[2] University of Heidelberg,Department of Experimental Surgery
[3] INF 365,Department of Orthopaedic Surgery
[4] University of Heidelberg,Department of Trauma and Reconstructive Surgery
[5] German Cancer Research Center,undefined
[6] INF 280,undefined
[7] Charité – Campus Benjamin Franklin,undefined
来源
BMC Cancer | / 6卷
关键词
Vascular Endothelial Growth Factor; Bone Metastasis; Celecoxib; Tumor Implantation; Intravital Microscopy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Celecoxib (a selective COX-2 inhibitor). Is the gastrointestinal toxicity of NSAIDs on its way out?
    Chaussade, S
    SEMAINE DES HOPITAUX, 1999, 75 (17-18): : 516 - 521
  • [22] COX-2 is induced by the COX-2 selective inhibitors celecoxib and etodolac and the non-selective inhibitor ibuprofen in several human tumor cell lines
    Schneider, Ryan
    Miller, Ian
    Renz, Mackenzie
    Whited, Tawna
    Kim, Lindsay
    Adams, Bryce
    Dudley, Richard
    Kinder, David
    FASEB JOURNAL, 2014, 28 (01):
  • [23] Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway
    Miyamoto, Katsuichi
    Miyake, Sachiko
    Mizuno, Miho
    Oka, Nobuyuki
    Kusunoki, Susumu
    Yamamura, Takashi
    BRAIN, 2006, 129 : 1984 - 1992
  • [24] Analysis of angiogenesis, microcirculation, and growth of primary and secondary bone tumors: An experimental study in mice
    Sckell, A
    Klenke, F
    Merkle, T
    Gebhard, MM
    Ewerbeck, V
    PROCEEDINGS OF THE 37TH CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH, 2002, : 165 - 168
  • [26] The effects of celecoxib, a novel COX-2 selective inhibitor, on arthritic conditions in rat adjuvant arthritis
    Kimoto, A
    Kobayashi, S
    Yoshino, T
    Noguchi, M
    Miyata, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 116P - 116P
  • [27] Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor
    Eibl, G
    Takata, Y
    Boros, LG
    Liu, J
    Okada, Y
    Reber, HA
    Hines, OJ
    CANCER RESEARCH, 2005, 65 (03) : 982 - 990
  • [28] A Study of the cytotoxic effects of cetuximab and the interaction with a selective Cox-2 inhibitor (Celecoxib) in breast cancer cell lines.
    Halaweh, Osama
    Yakan, Adli
    Lobocki, Catherine L.
    Drelichman, Anibal
    CANCER RESEARCH, 2006, 66 (08)
  • [29] Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53
    Katkoori, V. R.
    Manne, K.
    Vital-Reyes, V. S.
    Rodriguez-Burford, C.
    Shanmugam, C.
    Sthanam, M.
    Manne, U.
    Chatla, C.
    Abdulkadir, S. A.
    Grizzle, W. E.
    BIOTECHNIC & HISTOCHEMISTRY, 2013, 88 (01) : 38 - 46
  • [30] Growth inhibiting and apoptosis inducting effect of celecoxib (a selective COX-2 inhibitor) on K562 cells and their molecular mechanism
    Zhang, GS
    Liu, DS
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2004, 31 (12) : 1058 - 1066